Choroid Oligometastatic Lung Adenocarcinoma: Long-term Follow-up of a Radically Treated Patient
DOI:
https://doi.org/10.32932/Keywords:
Adenocarcinoma of Lung, Choroid Neoplasms/secondaryAbstract
Lung cancer is now the most frequently diagnosed cancer in the world and remains the most lethal, responsible for over 1.8 million deaths worldwide in 2022. However, a subset of limited metastatic disease seems to have a better outcome than multiple metastasis. Choroidal metastases of lung cancer usually occur in advanced stages, but isolated lesions have been treated successfully. We report a case of oligometastatic lung adenocarcinoma in the choroid, treated with upfront lung surgery, followed by systemic chemotherapy that did not require local adjuvant radiotherapy and remains free from progression 9 years after surgery.Downloads
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263. doi: 10.3322/caac.21834.
Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, et al. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023;13:393-412. doi: 10.1016/j.prro.2023.04.004.
Kourie HR, Antoun J, Schakal A, Nasr E, Sahyoun M, Kattan J. Complete disappearance of choroidal metastasis from lung adenocarcinoma treated with bevacizumab and chemotherapy. Case Rep Ophthalmol Med. 2015;2015:142408. doi: 10.1155/2015/142408.
Qu Z, Liu J, Zhu L, Zhou Q. A Comprehensive Understanding of Choroidal Metastasis from Lung Cancer. Onco Targets Ther. 2021;14:4451-4465. doi: 10.2147/OTT.S315532.
Niibe Y, Chang JY, Onishi H, Salama J, Hiraki T, Yamashita H. Oligometastases/Oligo-recurrence of lung cancer. Pulm Med. 2013;2013:438236. doi: 10.1155/2013/438236.
Liu S, Liu X, Wang T, Zeng C, Ren B, Yu X, et al. Effective Systemic Treatment of Choroidal Metastases NSCLC With Surgery After Crizotinib: A Case Report. Front Oncol. 2022;12:789941. doi: 10.3389/fonc.2022.789941.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author(s) (or their employer(s)) and THORAC 2024
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.